2-Hydrazinyl-4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidine

Catalog No. :
ACAIPE115
CAS No. :
832737-83-4
Molecular Formula :
C9H7F3N4S
Molecular Weight :
260.24

IUPAC Name:2-hydrazineyl-4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidine

2-Hydrazinyl-4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$130.00Login to see priceInquiryInquiry
250mg95%$388.00Login to see priceInquiryInquiry
1g95%$491.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Hydrazinyl-4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidine
IUPAC Name2-hydrazineyl-4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidine
MDL No.MFCD04969943
Molecular FormulaC9H7F3N4S
Molecular Weight260.24
SMILESFC(C1=CC(C2=CC=CS2)=NC(NN)=N1)(F)F
InChI KeyGXSYPILJVPHYFW-UHFFFAOYSA-N
Synonym2-hydrazino-4-thien-2-yl-6-(trifluoromethyl)pyrimidine;2-Hydrazinyl-4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidine;Pyrimidine, 2-hydrazinyl-4-(2-thienyl)-6-(trifluoromethyl)-
CAS No.832737-83-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAIPE115 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAIPE115 route product structure diagram
    ACAIPE115832737-83-4
Inquiry

2. ACAIPE115 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAIPE115 route product structure diagram
    ACAIPE115832737-83-4
Inquiry

Comments (0)